Yaling Li

837 total citations
40 papers, 572 citations indexed

About

Yaling Li is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Yaling Li has authored 40 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 13 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Yaling Li's work include Cancer-related molecular mechanisms research (9 papers), Cancer Immunotherapy and Biomarkers (4 papers) and RNA modifications and cancer (4 papers). Yaling Li is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Cancer Immunotherapy and Biomarkers (4 papers) and RNA modifications and cancer (4 papers). Yaling Li collaborates with scholars based in China, Sweden and Senegal. Yaling Li's co-authors include Yun Ye, Yan Qi, Jiting Wang, Hongyan Chen, Jun Li, Jun Li, Song Su, Duo Li, Tong Yue and Yuan Tian and has published in prestigious journals such as European Heart Journal, Frontiers in Immunology and The American Journal of Gastroenterology.

In The Last Decade

Yaling Li

37 papers receiving 570 citations

Peers

Yaling Li
Weixiong Chen China
Quanbao Zhang China
Zijing Xia China
Jingwen Xia China
Yan Xue China
Zun Wang China
Yajie Wang China
Jia Shi China
Lijun Sun China
Weixiong Chen China
Yaling Li
Citations per year, relative to Yaling Li Yaling Li (= 1×) peers Weixiong Chen

Countries citing papers authored by Yaling Li

Since Specialization
Citations

This map shows the geographic impact of Yaling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaling Li more than expected).

Fields of papers citing papers by Yaling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaling Li. The network helps show where Yaling Li may publish in the future.

Co-authorship network of co-authors of Yaling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yaling Li. A scholar is included among the top collaborators of Yaling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaling Li. Yaling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Simin, Huaping Dong, Pei Huang, et al.. (2025). Changes in body composition during acute exposure to high altitude is related to acute mountain sickness. Travel Medicine and Infectious Disease. 64. 102815–102815.
2.
Li, Yaling, Xiangyang Liu, Xiaoli Tan, et al.. (2024). Aloe Emodin Alleviates Radiation‐Induced Heart Disease via Blocking P4HB Lactylation and Mitigating Kynurenine Metabolic Disruption. Advanced Science. 11(47). e2406026–e2406026. 14 indexed citations
3.
Li, Jun, et al.. (2023). The efficacy and safety of trastuzumab deruxtecan (T-DXd) in HER2-expressing solid tumours: a single-arm meta-analysis. Japanese Journal of Clinical Oncology. 53(8). 722–729. 8 indexed citations
4.
Li, Bo, et al.. (2023). The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma. Cancer Immunology Immunotherapy. 72(12). 3953–3969. 6 indexed citations
5.
6.
Wen, Qinglian, et al.. (2023). Incidence and risk of hypertension associated with PARP inhibitors in cancer patients: a systematic review and meta-analysis. BMC Cancer. 23(1). 107–107. 6 indexed citations
7.
Zhang, Lei, Ziyi Wang, Kezhi Liu, Jun Li, & Yaling Li. (2023). Investigation of the relationship between heavy metals in the blood and depression in people with different body mass indices using the NHANES database: A cross-sectional study. Journal of Affective Disorders. 344. 311–318. 7 indexed citations
8.
He, Bin, et al.. (2023). The effect of hyperbaric oxygen therapy on the clinical outcomes of necrotizing soft tissue infections: a systematic review and meta-analysis. World Journal of Emergency Surgery. 18(1). 23–23. 24 indexed citations
9.
10.
Wu, Yu, Simin Zhou, Hong Li, et al.. (2022). Remote ischemic preconditioning enhances aerobic performance by accelerating regional oxygenation and improving cardiac function during acute hypobaric hypoxia exposure. Frontiers in Physiology. 13. 950086–950086. 7 indexed citations
11.
Yuan, Ping, et al.. (2022). Nilotinib in Parkinson's disease: A systematic review and meta-analysis. Frontiers in Aging Neuroscience. 14. 996217–996217. 12 indexed citations
12.
Wen, Qinglian, et al.. (2022). Adverse events of immune checkpoint inhibitors for patients with digestive system cancers: A systematic review and meta-analysis. Frontiers in Immunology. 13. 1013186–1013186. 5 indexed citations
13.
Li, Yaling, et al.. (2022). Comprehensive Diagnostics of Diabetic Nephropathy by Transcriptome RNA Sequencing. Diabetes Metabolic Syndrome and Obesity. Volume 15. 3069–3080. 6 indexed citations
14.
Li, Yaling, et al.. (2022). Remote ischemic preconditioning improves cognitive control in healthy adults: Evidence from an event-related potential study. Frontiers in Neuroscience. 16. 936975–936975. 4 indexed citations
15.
Wang, Jiting, Song Su, Jun Li, & Yaling Li. (2021). Efficacy and Safety of Camrelizumab Monotherapy and Combination Therapy for Cancers: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 695512–695512. 10 indexed citations
16.
Li­, ­Jun, et al.. (2021). Incidence and Risk of Hypertension in Cancer Patients Treated With Atezolizumab and Bevacizumab: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 726008–726008. 2 indexed citations
17.
Xue, Ling, Xiaowen Zhao, Xiaojie Jin, et al.. (2021). Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma. International Journal of General Medicine. Volume 14. 6463–6475. 20 indexed citations
18.
Xu, Jing, et al.. (2020). Hyperlipoproteinemia (a) is associated with breast cancer in a Han Chinese population. Medicine. 99(38). e22037–e22037. 8 indexed citations
19.
Fang, Shun, Bin Chen, Longfei Jia, et al.. (2018). H3K27me3 induces multidrug resistance in small cell lung cancer by affecting HOXA1 DNA methylation via regulation of the lncRNA HOTAIR. Annals of Translational Medicine. 6(22). 440–440. 48 indexed citations
20.
Li, Yaling, Yun Ye, & Hongyan Chen. (2018). Astragaloside IV inhibits cell migration and viability of hepatocellular carcinoma cells via suppressing long noncoding RNA ATB. Biomedicine & Pharmacotherapy. 99. 134–141. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weixiong Chen Breakdown of academic impact, for papers by Quanbao Zhang Breakdown of academic impact, for papers by Zijing Xia Breakdown of academic impact, for papers by Jingwen Xia Breakdown of academic impact, for papers by Yan Xue Breakdown of academic impact, for papers by Zun Wang Breakdown of academic impact, for papers by Yajie Wang Breakdown of academic impact, for papers by Jia Shi Breakdown of academic impact, for papers by Lijun Sun
Rankless by CCL
2026